Clinical Trials Sponsored by Vivolux AB

Total 988 results

Vivolux AB
Theradex

Terminated

A Study of VLX1570 and Dexamethasone in Myeloma Patients

Multiple Myeloma

United States
Vivolux AB
Theradex

Terminated

Study of Safety and Tolerability of VLX600, an Iron Chelator, in Patients With Refractory Advanced Solid Tumors

Refractory Cancer

United States
Airsonett AB
Commitum AB; Croel AB

Completed

Efficacy Study of Temperature Controlled Laminar Airflow (TLA)-Treatment in Perennial Allergic Asthma (4A)

Asthma

Denmark, United Kingdom, Norway, Sweden, Germany, Finland
Ostomycure AB
Devicia AB

Unknown

Safety, Performance and Durability of the TIES® Implant in Patients Requiring a Permanent Ileostomy

Ileostomy - Stoma

Sweden, United Kingdom
DermaGen AB
Pergamum AB

Completed

A Study of DPK-060 to Investigate Clinical Safety and Efficacy in Patients With Acute External Otitis

Acute Otitis Externa

Sweden
Amplicon AB

Recruiting

Study to Assess PK, PD, Nicotine Extraction, Palatability, Subjective Effects of Nicotine Pouches - Daily Nicotine Users

Nicotine Use Disorder

Sweden
Aventure AB
Glucanova AB

Completed

Effects of a Whole Grain Cereal Product on Blood Glucose Response After 3 Consecutive Meals

Blood Glucose

Sweden
Pharmiva AB
Key2Compliance; Replior AB

Completed

A User Study With Vernivia® for Bacterial Vaginosis. (USV01)

Bacterial Vaginoses

Sweden
Aventure AB
Berry Lab AB

Completed

Study on the Chronic and Acute Effects of Nordic Berry Beverage on Cognitive Function (SCANBerry)

Age-related Cognitive Decline

Sweden
NeuroVive Pharmaceutical AB

Completed

Copenhagen Head Injury Ciclosporin (CHIC) Study (CHIC)

Traumatic Brain Injury

Denmark
NeuroVive Pharmaceutical AB

Completed

A Study to Compare the Bioavailability and Pharmacokinetics of Cyclosporine After Intravenous Administration of NEUROSTAT®, a CREMOPHOR® EL-free Lipid Emulsion, and SANDIMMUNE® Injection (a Suspension of Cyclosporine in CREMOPHOR® EL) in Healthy Volunteers

Healthy

South Africa
Attgeno AB
Scandinavian CRO AB

Recruiting

A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in Patients With Pulmonary Hypertension After Cardiopulmonary Bypass Surgery

Pulmonary Hypertension

Sweden
DoubleGood AB
Lund University; Aventure AB

Completed

Efficacy of Different Doses of Amino Acids in 5AA+CrPic Water on Glucose Homeostasis in a Healthy Population.

Healthy
CytaCoat AB

Recruiting

Evaluation of Safety and Performance of the CytaCoat Lubricious Infection Prevention (LIP) Foley Catheter

Safety of the CytaCoat LIP Foley Catheter | Tolerability of the CytaCoat LIP Foley Catheter

Sweden
BONESUPPORT AB

Not yet recruiting

CERAMENT G Device Registry

Diabetic Foot Osteomyelitis | Chronic Osteomyelitis | Fracture Related Infection
Acorai AB

Recruiting

Acorai MLG Study (Machine Learning Generalisation)

Heart Failure

United Kingdom
Oncorena AB

Recruiting

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

Carcinoma, Renal Cell

Sweden
AB Science

Recruiting

Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19

COVID-19 | SARS-CoV 2 | Coronavirus Disease 2019

France
NeoDynamics AB

Recruiting

Comparison Trial of Open-tip Pulsed Needle Biopsy and Conventional Core Biopsy in Axillary Lymph Nodes (COMPULSE)

Breast Cancer

United Kingdom
TikoMed AB

Recruiting

Study to Evaluate Safety and Efficacy of IBsolvMIR in Islet Transplantation

Diabetes Mellitus, Type 1

Sweden, Norway, Netherlands
Camurus AB

Active, not recruiting

A Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly

Acromegaly

United States, Spain, United Kingdom, Germany, Russian Federation, Greece, Hungary, Italy, Poland, Turkey, Serbia
Camurus AB

Active, not recruiting

A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLD (POSITANO)

Polycystic Liver Disease

United States, Germany, Belgium, Netherlands
Aventure AB

Active, not recruiting

Evaluation of an Herbal Extract on Sleep Parameters

Sleep Onset Latency

Sweden
Oncopeptides AB

Terminated

A Study of Melphalan Flufenamide (Melflufen)-Dex or Pomalidomide-dex for RRMM Patients Refractory to Lenalidomide (OCEAN)

Multiple Myeloma

United States, Austria, Belgium, Czechia, Denmark, Estonia, France, Greece, Hungary, Israel, Italy, Korea, Republic of, Lithuania, Netherlands, Norway, Poland, Romania, Russian Federation, Spain, Taiwan, United Kingdom
Probi AB

Completed

Probiotic Intervention for Stress and Cognition

Stress | Cognition

Ireland
Cantargia AB

Active, not recruiting

A First-in-Human Study of CAN04 in Patients With Solid Malignant Tumors (CANFOUR)

Colorectal Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Pancreatic Ductal Adenocarcinoma

Austria, Denmark, Germany, Belgium, Spain, Latvia, Netherlands, Lithuania, Estonia, Sweden, Norway
AB Science

Completed

Masitinib Plus Docetaxel in Metastatic Castration-resistant Prostate Cancer

Metastatic Castrate Resistant Prostate Cancer

Italy, Russian Federation, India, Canada, France, Malaysia
AB Science

Completed

Masitinib in Patients With Mild to Moderate Alzheimer's Disease

Alzheimer Disease

Spain, Bulgaria, Greece, Poland, Romania, Ukraine
Kancera AB

Terminated

KAND567 Versus Placebo in Subjects Hospitalized With COVID-19

Covid19

Denmark, Sweden
AQILION AB

Completed

SAD, MAD and Food Effect Evaluation of Safety, Tolerability, and PK of AQ280 in Healthy Subjects

Eosinophilic Esophagitis (EoE)

United Kingdom
Oncopeptides AB

Terminated

Study of Melflufen (Melphalan Flufenamide) in Combination With Daratumumab in Relapsed-Refractory Multiple Myeloma (LIGHTHOUSE)

Relapsed Multiple Myeloma | Relapsed-Refractory Multiple Myeloma

Serbia, Greece, Russian Federation, Czechia, Bulgaria, Georgia, Norway, Poland, Spain, Ukraine, Germany
Amniotics AB

Completed

A First-In-Human Phase 1b Study of AmnioPul-02 in COVID-19 / Other LRTI

COVID-19

Sweden
Oncopeptides AB

Terminated

Study of Melphalan Flufenamide (Melflufen) + Dex With Bortezomib or Daratumumab in Patients With RRMM (ANCHOR)

Multiple Myeloma

United States, France, Spain, Czechia
AB Biotek

Completed

Efficacy and Tolerability of ABBC1 in Volunteers Receiving the Influenza or Covid-19 Vaccine

Immunologic Deficiency Syndromes | Covid19 | Vaccine Reaction | Influenza | Immunity | Cytokine Storm

Spain
Aventure AB

Completed

Second Meal Effects of a Wholegrain Cereal Product on Blood Glucose Response

Blood Glucose Response

Sweden
BioGaia AB

Completed

Study Evaluating the Safety and Tolerability of a Probioitc

Healthy Volunteers | Tolerability | Safety

Sweden
Oncopeptides AB

Withdrawn

A Study of OPD5 Followed by Autologous Stem Cell Transplant for Patients With Relapsed Refractory Multiple Myeloma (COAST)

Multiple Myeloma | Relapse Multiple Myeloma

Czechia
BioGaia AB

Completed

Study Evaluating the Safety and Tolerability

Healthy Volunteers

Sweden
Oncopeptides AB

Approved for marketing

Expanded Access Program for Melphalan Flufenamide (Melflufen) in Triple Class Refractory Multiple Myeloma (sEAPort)

Relapsed and/or Refractory Multiple Myeloma

United States
Bactiguard AB

Completed

VITAL - VAP Prevention by BIP (Bactiguard Infection Protection) ETT Evac in Belgian ICUs (VITAL)

Ventilator-associated Pneumonia

Belgium
BioGaia AB

Completed

Double-blinded, Randomized, Placebo-controlled Study Evaluating the Effect of the Probiotic on Recurrent Urinary Tract Infection

Recurrent Urinary Tract Infection in Adult Women

Sweden
AB Science

Completed

Masitinib in the Treatment of Patients With Severe Uncontrolled Asthma and Elevated Eosinophil Levels

Asthma

Malaysia, Argentina, Peru, Philippines, Ukraine
AB Science

Completed

Masitinib in Combination With FOLFIRI in Third or Fourth Line of Treatment of Patients With Metastatic Colorectal Cancer

Colorectal Cancer Metastatic

Czechia, France, Russian Federation, Spain, United Kingdom
AB Science

Completed

Masitinib in Combination With Gemcitabine in Advanced/Metastatic Epithelial Ovarian Cancer Patients

Ovarian Cancer

France, United Kingdom, Ukraine, Algeria, Russian Federation, Spain
Enzymatica AB

Completed

Evaluation of ColdZyme® Mouth Spray on Prevention and Alleviation of Rhinovirus Induced Common Cold (COLDPREV)

Common Cold
AB Science

Terminated

Masitinib in Non-Resectable or Metastatic Stage 3/4 Melanoma Carrying a Mutation in the Juxta Membrane Domain of c-Kit

Metastatic Melanoma

France, Spain, Italy, United States, Czechia, Germany, Russian Federation
Dilafor AB

Completed

Effect of Tafoxiparin to Treat Primary Slow Progress of Labor Including Prolonged Latent Phase and Labor Arrest

Labor, Obstetric

Finland, Sweden, Denmark
AB Science

Completed

Efficacy and Safety of Masitinib in the Treatment of Progressive Multiple Sclerosis

Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Relapse Free

Poland, Spain, Bulgaria, France, Germany, Greece, Romania
Probi AB

Terminated

Probiotics in Radiation-treated Gynecologic Cancer (ProRad)

Gynecologic Cancer | Gastrointestinal Toxicity

Sweden
Probi AB

Completed

Efficacy of Probiotics on Iron Status During Pregnancy

Prevention of Iron Deficiency

Sweden

Clinical Trials Sponsored by Vivolux AB

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations